Clague Laura
Insider CIK 1388773 · FLDM Director · RTRX Chief Financial Officer · LRAD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LAB STANDARD BIOTOOLS INC. | A Award deriv | 2023-06-14 | 2023-06-16 | 35,380 | — | $0 | 35,380 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award | 2023-06-14 | 2023-06-16 | 26,376 | — | $0 | 104,791 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award deriv | 2022-06-15 | 2022-06-17 | 42,571 | — | $0 | 42,571 | SEC↗ |
| LAB STANDARD BIOTOOLS INC. | A Award | 2022-06-15 | 2022-06-17 | 30,914 | — | $0 | 78,415 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-12 | 1,375 | $21.51 | $29.6K | 35,655 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-10 | 2022-05-12 | 825 | $21.51 | $17.7K | 37,030 | SEC↗ |
| GNSS Genasys Inc. | M Exercise deriv | 2022-04-27 | 2022-04-27 | 50,000 | — | $0 | 0 | SEC↗ |
| GNSS Genasys Inc. | M Exercise | 2022-04-27 | 2022-04-27 | 50,000 | $1.33 | $66.5K | 284,311 | SEC↗ |
| GNSS Genasys Inc. | A Award | 2022-03-15 | 2022-03-17 | 30,000 | — | $0 | 234,311 | SEC↗ |
| GNSS Genasys Inc. | M Exercise deriv | 2022-02-23 | 2022-02-24 | 20,000 | — | $0 | 0 | SEC↗ |
| GNSS Genasys Inc. | S Sale | 2022-02-23 | 2022-02-24 | 13,716 | $3.14 | $43.1K | 204,311 | SEC↗ |
| GNSS Genasys Inc. | M Exercise | 2022-02-23 | 2022-02-24 | 20,000 | $2.16 | $43.2K | 218,027 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 9,840 | — | $0 | 9,840 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 39,360 | — | $0 | 39,360 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-31 | 2022-02-02 | 1,238 | $27.40 | $33.9K | 37,855 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-01-31 | 2022-02-02 | 9,840 | — | $0 | 39,093 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-24 | 2022-01-26 | 2,063 | $24.98 | $51.5K | 29,253 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-11 | 2022-01-12 | 7,500 | $27.40 | $205.5K | 31,316 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-01-10 | 2022-01-12 | 7,500 | — | $0 | 38,816 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-08-17 | 2021-08-17 | 1,407 | $17.12 | $24.1K | 31,316 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-08-13 | 2021-08-17 | 4,500 | — | $0 | 32,723 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award deriv | 2021-05-25 | 2021-05-27 | 15,402 | — | $0 | 15,402 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award | 2021-05-25 | 2021-05-27 | 10,342 | — | $0 | 47,501 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-12 | 2021-05-13 | 2,000 | $19.46 | $38.9K | 28,223 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 2,000 | $19.14 | $38.3K | 30,223 | SEC↗ |
| GNSS Genasys Inc. | A Award | 2021-03-16 | 2021-03-18 | 27,883 | — | $0 | 168,027 | SEC↗ |
| GNSS Genasys Inc. | M Exercise deriv | 2021-03-10 | 2021-03-12 | 20,000 | — | $0 | 0 | SEC↗ |
| GNSS Genasys Inc. | M Exercise | 2021-03-10 | 2021-03-12 | 20,000 | $2.02 | $40.4K | 175,600 | SEC↗ |
| GNSS Genasys Inc. | S Sale | 2021-03-10 | 2021-03-12 | 5,456 | $7.42 | $40.5K | 170,144 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award | 2021-02-20 | 2021-02-23 | 9,803 | — | $0 | 37,159 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-08 | 2021-02-09 | 2,250 | $31.58 | $71.1K | 32,223 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-05 | 2021-02-09 | 2,250 | $31.41 | $70.7K | 34,473 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 2,500 | $28.91 | $72.3K | 33,348 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 1,125 | $28.91 | $32.5K | 32,223 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-02-03 | 2021-02-05 | 4,500 | — | $0 | 36,723 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 2,500 | $30.75 | $76.9K | 36,973 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 1,125 | $30.75 | $34.6K | 35,848 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-31 | 2021-02-02 | 5,000 | — | $0 | 39,473 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-01-21 | 2021-01-25 | 57,500 | — | $0 | 57,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-21 | 2021-01-25 | 15,000 | — | $0 | 34,473 | SEC↗ |
| RTRX Travere Therapeutics, Inc. | S Sale | 2020-11-25 | 2020-11-25 | 3,750 | $22.72 | $85.2K | 19,473 | SEC↗ |
| RTRX Travere Therapeutics, Inc. | S Sale | 2020-11-24 | 2020-11-25 | 3,750 | $23.86 | $89.5K | 23,223 | SEC↗ |
| RTRX Travere Therapeutics, Inc. | A Award | 2020-11-23 | 2020-11-25 | 7,500 | — | $0 | 26,973 | SEC↗ |
| RTRX Travere Therapeutics, Inc. | S Sale | 2020-11-16 | 2020-11-17 | 7,500 | $23.98 | $179.8K | 19,473 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-11-13 | 2020-11-13 | 7,500 | $23.61 | $177.1K | 26,973 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-11-11 | 2020-11-13 | 15,000 | — | $0 | 34,473 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-23 | 2020-09-23 | 1,500 | $18.48 | $27.7K | 19,473 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-22 | 2020-09-22 | 1,500 | $18.59 | $27.9K | 20,973 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 22,473 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award deriv | 2020-06-23 | 2020-06-25 | 20,993 | — | $0 | 20,993 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award | 2020-06-23 | 2020-06-25 | 13,369 | — | $0 | 27,356 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 527 | $16.98 | $8.9K | 19,473 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-12 | 2020-05-13 | 1,250 | $17.16 | $21.4K | 20,000 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-11 | 2020-05-13 | 1,250 | $14.95 | $18.7K | 21,250 | SEC↗ |
| LRAD Genasys Inc. | M Exercise deriv | 2020-03-12 | 2020-03-12 | 30,000 | — | $0 | 0 | SEC↗ |
| LRAD Genasys Inc. | M Exercise | 2020-03-12 | 2020-03-12 | 30,000 | — | $0 | 155,600 | SEC↗ |
| LRAD LRAD Corp | A Award deriv | 2020-03-12 | 2019-03-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| LRAD Genasys Inc. | A Award | 2020-03-10 | 2020-03-12 | 30,000 | — | $0 | 125,600 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-03-10 | 2020-03-12 | 4,000 | $15.02 | $60.1K | 22,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-03-05 | 2020-03-09 | 4,000 | — | $0 | 26,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 22,500 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award deriv | 2019-06-03 | 2019-06-05 | 6,796 | — | $0 | 6,796 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award | 2019-06-03 | 2019-06-05 | 3,987 | — | $0 | 13,987 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-05-16 | 2019-05-16 | 1,250 | $18.71 | $23.4K | 13,500 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-05-15 | 2019-05-16 | 1,250 | $17.78 | $22.2K | 14,750 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 16,000 | SEC↗ |
| LRAD LRAD Corp | M Exercise deriv | 2019-03-20 | 2019-03-20 | 25,000 | — | $0 | 0 | SEC↗ |
| LRAD LRAD Corp | M Exercise | 2019-03-20 | 2019-03-20 | 25,000 | — | $0 | 95,600 | SEC↗ |
| LRAD LRAD Corp | A Award deriv | 2019-03-12 | 2019-03-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-12 | 2019-02-13 | 1,016 | $21.50 | $21.8K | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-11 | 2019-02-13 | 1,017 | $21.38 | $21.7K | 11,016 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-12-21 | 2018-12-21 | 900 | $22.34 | $20.1K | 12,033 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-12-21 | 2018-12-21 | 2,850 | $21.67 | $61.8K | 12,933 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-12-20 | 2018-12-21 | 3,750 | $22.08 | $82.8K | 15,783 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-12-18 | 2018-12-20 | 7,500 | — | $0 | 19,533 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 791 | $24.73 | $19.6K | 12,033 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 2,959 | $24.20 | $71.6K | 12,824 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-14 | 2018-11-16 | 400 | $24.54 | $9.8K | 15,783 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-14 | 2018-11-16 | 3,350 | $23.63 | $79.2K | 16,183 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-11-09 | 2018-11-14 | 7,500 | — | $0 | 19,533 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award deriv | 2018-10-30 | 2018-11-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FLDM FLUIDIGM CORP | A Award | 2018-10-30 | 2018-11-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 48,000 | — | $0 | 48,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-10 | 2018-05-14 | 10,000 | — | $0 | 12,033 | SEC↗ |
| LRAD LRAD Corp | A Award deriv | 2018-03-20 | 2018-03-21 | 25,000 | — | $0 | 95,600 | SEC↗ |
| LRAD LRAD Corp | M Exercise deriv | 2018-03-14 | 2018-03-16 | 25,000 | — | $0 | 70,600 | SEC↗ |
| LRAD LRAD Corp | M Exercise | 2018-03-14 | 2018-03-16 | 25,000 | — | $0 | 70,600 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-02-08 | 2018-02-12 | 2,033 | — | $0 | 2,033 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-05-17 | 2017-05-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| LRAD LRAD Corp | M Exercise deriv | 2017-05-17 | 2017-05-19 | 25,000 | — | $0 | 0 | SEC↗ |
| LRAD LRAD Corp | M Exercise | 2017-05-17 | 2017-05-19 | 25,000 | — | $0 | 47,600 | SEC↗ |
| LRAD LRAD Corp | A Award deriv | 2017-03-14 | 2017-03-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LRAD LRAD Corp | A Award deriv | 2017-03-14 | 2017-03-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2016-05-19 | 2016-05-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2015-07-01 | 2015-07-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| LRAD LRAD Corp | A Award deriv | 2015-03-18 | 2015-03-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2014-11-17 | 2014-11-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| LRAD LRAD Corp | A Award deriv | 2014-03-26 | 2014-03-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LRAD LRAD Corp | M Exercise deriv | 2013-09-04 | 2013-09-06 | 30,000 | — | $0 | 0 | SEC↗ |
| LRAD LRAD Corp | S Sale | 2013-09-04 | 2013-09-06 | 9,400 | $1.54 | $14.5K | 22,600 | SEC↗ |
| LRAD LRAD Corp | M Exercise | 2013-09-04 | 2013-09-06 | 30,000 | $0.48 | $14.4K | 32,000 | SEC↗ |
| LRAD LRAD Corp | A Award deriv | 2012-05-10 | 2012-05-10 | 50,000 | — | $0 | 50,000 | SEC↗ |